TEPADINA powder for concentrate for solution for infusion, 15 mg and 100 mg

Drug product contains the API Thiotepa in a dose of 15 mg or 100 mg per vial.

Tepadina is indicated, in combination with other chemotherapy medicinal products:

1) with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients;

2) when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.